Smooth muscle cell signal transduction: Implications of vascular biology for vascular surgeons
Received 18 January 2007; accepted 17 February 2007.
Vascular smooth muscle cells exhibit varied responses after vessel injury and surgical interventions, including phenotypic switching, migration, proliferation, protein synthesis, and apoptosis. Although the source of the smooth muscle cells that accumulate in the vascular wall is controversial, possibly reflecting migration from the adventitia, from the circulating blood, or in situ differentiation, the intracellular signal transduction pathways that control these processes are being defined. Some of these pathways include the Ras-mitogen–activated protein kinase, phosphatidylinositol 3-kinase-Akt, Rho, death receptor-caspase, and nitric oxide pathways. Signal transduction pathways provide amplification, redundancy, and control points within the cell and culminate in biologic responses. We review some of the signaling pathways activated within smooth muscle cells that contribute to smooth muscle cell heterogeneity and development of pathology such as restenosis and neointimal hyperplasia.
aDepartments of Surgery, Yale University School of Medicine, New Haven, Conn
bInterdepartmental Program in Vascular Biology and Transplantation, Yale University School of Medicine, New Haven, Conn
eVA Connecticut Healthcare System, West Haven, Conn
Reprint requests: Alan Dardik, MD, PhD, Yale University School of Medicine, Boyer Center for Molecular Medicine, 295 Congress Ave, Room 436, New Haven, CT 06519.
Competition of interest: none.
This material is the result of work partially supported by National Institutes of Health awards 1 K08 HL079927 (A. D.) and 1 F32 HL086086 (T. N. F.), the American Vascular Association William J. von Liebig Award, as well as with resources and the use of facilities at the VA Connecticut Healthcare System, West Haven, Connecticut.